Imbalanced matrix metalloproteinases in cardiovascular complications of end-stage kidney disease: a potential pharmacological target (2012)
- Authors:
- Autor USP: SANTOS, JOSE EDUARDO TANUS DOS - FMRP
- Unidade: FMRP
- DOI: 10.1111/j.1742-7843.2012.00863.x
- Subjects: ARTERIOSCLEROSE; DOENÇAS CARDIOVASCULARES; INSUFICIÊNCIA RENAL CRÔNICA; METALOPROTEINASES; UREMIA
- Language: Inglês
- Imprenta:
- Publisher place: West Sussex
- Date published: 2012
- Source:
- Título: Basic and Clinical Pharmacology and toxicology
- ISSN: 1742-7851
- Volume/Número/Paginação/Ano: v. 110, n. 5, p. 409-415, 2012
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: bronze
-
ABNT
MARSON, Bernardo P. e FIGUEIREDO, Carlos E. Poli de e SANTOS, José Eduardo Tanus dos. Imbalanced matrix metalloproteinases in cardiovascular complications of end-stage kidney disease: a potential pharmacological target. Basic and Clinical Pharmacology and toxicology, v. 110, n. 5, p. 409-415, 2012Tradução . . Disponível em: https://doi.org/10.1111/j.1742-7843.2012.00863.x. Acesso em: 09 jan. 2026. -
APA
Marson, B. P., Figueiredo, C. E. P. de, & Santos, J. E. T. dos. (2012). Imbalanced matrix metalloproteinases in cardiovascular complications of end-stage kidney disease: a potential pharmacological target. Basic and Clinical Pharmacology and toxicology, 110( 5), 409-415. doi:10.1111/j.1742-7843.2012.00863.x -
NLM
Marson BP, Figueiredo CEP de, Santos JET dos. Imbalanced matrix metalloproteinases in cardiovascular complications of end-stage kidney disease: a potential pharmacological target [Internet]. Basic and Clinical Pharmacology and toxicology. 2012 ; 110( 5): 409-415.[citado 2026 jan. 09 ] Available from: https://doi.org/10.1111/j.1742-7843.2012.00863.x -
Vancouver
Marson BP, Figueiredo CEP de, Santos JET dos. Imbalanced matrix metalloproteinases in cardiovascular complications of end-stage kidney disease: a potential pharmacological target [Internet]. Basic and Clinical Pharmacology and toxicology. 2012 ; 110( 5): 409-415.[citado 2026 jan. 09 ] Available from: https://doi.org/10.1111/j.1742-7843.2012.00863.x - Antihypertensive effects exerted by enalapril in mild to moderate hypertension are not associated with changes in the circulating levels of nitric oxide-related markers
- Vascular endothelial growth factor haplotypes associated with childhood obesity
- Severity dependent increases in circulating cardiac troponin I and MMP-9 concentrations after experimental acute pulmonary thromboembolism
- Matrix metalloproteinase-9 genetic variation affect MMP-9 levels in obese children
- Simvastatin treatment increases nitrite levels in obese women: Modulation by T−786C polymorphism of eNOS
- Antihypertensive effects of inducible nitric oxide synthase inhibition in experimental pre-eclampsia
- Sildenafil improves the beneficial hemodynamic effects exerted by atorvastatin during acute pulmonary thromboembolism
- Hemodynamic effects of bupropion in anesthetized dogs
- Hemodynamic effects of sildenafil interaction with a nitric oxide donor compound in a dog model of acute pulmonary embolism
- Vascular xanthine oxidoreductase contributes to the antihypertensive effects of sodium nitrite in L-NAME hypertension
Informações sobre o DOI: 10.1111/j.1742-7843.2012.00863.x (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
